Angelique M. Salib
Angelique Salib is an associate at Bass, Berry & Sims PLC, in their Washington, D.C. office. She provides healthcare regulatory counsel as it relates to compliance, operational and transactional matters through applicable components of the Stark Law, Anti-Kickback Statute (AKS), Medicare reimbursement, managed care, in addition to clinical research and life sciences matters. She also works with hospital and health system clients on contractual arrangements and a broad range of compliance matters.
Angelique earned her law degree from The University of Chicago Law School where she also earned a Graduate Program in Health Administration and Policy (GPHAP) Certificate and was awarded the Erikson Fellowship for her work at a Chicago-area hospital. Angelique is a member of the American Health Law Association (AHLA) and served on the Hospitals and Health Systems practice group in the Leadership Development Program from 2020-2021.
Memberships
American Health Law Association (AHLA) — Leadership Development Program (2020-2021)
Representative Experience
-
Read More
Representation of Addus HomeCare Corporation (NASDAQ: ADUS) in its $29.1 million acquisition of three affiliated entities: Armada Skilled Home Care of New Mexico, LLC, Armada Hospice of New Mexico, LLC and Armada Hospice of Santa Fe, LLC. This acquisition expands Addus HomeCare’s home health and hospice services in the state of New Mexico.
-
Read More
Advise a public university system on compliance with the rules associated with grants and contracts from NIH, NSF, and the Department of Defense
-
Read More
Representation of Brookdale Senior Living Inc. (NYSE: BKD) in its definitive agreement to sell 80 percent of Brookdale Health Care Services, the Brentwood-based company’s home health and outpatient therapy division, to HCA Healthcare (NYSE: HCA), one of the nation’s leading healthcare providers, in an all-cash transaction for $400 million
-
Read More
Representation of Humana Innovation Enterprises Inc. (affiliated with Humana Inc.) in its minority joint venture investment in Summit Medical Group, East Tennessee’s largest primary care organization.
-
Read More
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
-
Read More
Representation of Grant Avenue Capital, a healthcare-focused middle-market private equity firm, in its acquisition of Hearts for Hospice, LLC a full-service Utah hospice and home health agency, and Abode Healthcare, Inc., a home health care provider.
-
Read More
Assisted a prominent children’s hospital with a range of industry-sponsored and investigator-initiated research agreements
-
Read More
Representation of Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in its definitive agreement to acquire Queen City Hospice, LLC, and its affiliate Miracle City Hospice, LLC for a cash purchase price of $192.0 million
Publications
Media Mentions & Firm News
Additional News & Insights
Publications
- “When the Planet of the Apes Becomes the Planet of A.I.,” AHLA Connections (May 2019)
- “Strategies for Acing the Fundamentals and Mitigating Legal and Ethical Consequences of Poor Physician-Patient Communication,” AMA Journal of Ethics (March 2017)
- “Cover Data-Breach Risk in Licensing Agreements,” American Society of Association Executives (April 2016)